Report post
BioXcel Therapeutics pioneers neuroscience and immuno-oncology drug development. Collaborating with Acellera Therapeutics for small molecule discovery, Cramer predicts this biotech stock could soar to over $100 billion on FDA approval. Century Therapeutics adds to the mix, driving innovation in the healthcare sector. Stay tuned for breakthroughs in these cutting-edge fields.

The World's Leading Crypto Trading Platform

Get my welcome gifts